Frontlight ResearchEarly access
Fabry disease trials in China
3 of 7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEvaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
- Where
- Hangzhou, Shanghai
- Age
- 7 years and over
- People
- 12
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT06539624 - Phase 1/2Not yet taking people in ChinaThe Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease
- Where
- Hangzhou, Nanjing
- Age
- 18 years and over
- People
- 16
- Run by
- Guangzhou Jiayin Biotech Ltd
See details and how to joinNCT06819514 - Early phase 1Taking peopleEvaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease
- Where
- Shanghai
- Age
- 7 years to 18 years
- People
- 6
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT06207552